Literature DB >> 22939190

Modulation of HIV reservoirs by host HLA: bridging the gap between vaccine and cure.

Zabrina L Brumme1, Denis R Chopera, Mark A Brockman.   

Abstract

Latent HIV reservoirs are the greatest challenge facing an HIV cure. Here, we review recent evidence supporting an important role for the host immune response, in particular HLA class I-restricted CD8+ T lymphocytes, in modulating HIV reservoirs during natural infection. These observations indicate that factors governing immune-mediated control of HIV may also contribute to the clearance of viral reservoirs. As such, critical gaps in our understanding of HIV immunology hinder efforts to develop both an effective HIV vaccine as well as novel therapies that may lead to a cure. The importance of elucidating correlates of protective cellular immunity should be recognized during research to develop and test potential HIV elimination strategies.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22939190     DOI: 10.1016/j.coviro.2012.08.003

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  7 in total

1.  Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.

Authors:  Edurne Garcia-Vidal; Marc Castellví; Maria Pujantell; Roger Badia; Antoni Jou; Lucia Gomez; Teresa Puig; Bonaventura Clotet; Ester Ballana; Eva Riveira-Muñoz; José A Esté
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

2.  Emerging Nanomedicine Approaches to Targeting HIV-1 and Antiretroviral Therapy.

Authors:  Hilliard L Kutscher; Paras N Prasad; Gene D Morse; Jessica L Reynolds
Journal:  Future Virol       Date:  2016-02-03       Impact factor: 1.831

3.  Molecular and Genetic Characterization of HIV-1 Tat Exon-1 Gene from Cameroon Shows Conserved Tat HLA-Binding Epitopes: Functional Implications.

Authors:  Georges Teto; Julius Y Fonsah; Claude T Tagny; Dora Mbanya; Emilienne Nchindap; Leopoldine Kenmogne; Joseph Fokam; Dora M Njamnshi; Charles Kouanfack; Alfred K Njamnshi; Georgette D Kanmogne
Journal:  Viruses       Date:  2016-07-18       Impact factor: 5.048

Review 4.  Human Leukocyte Antigen Diversity: A Southern African Perspective.

Authors:  Mqondisi Tshabalala; Juanita Mellet; Michael S Pepper
Journal:  J Immunol Res       Date:  2015-08-12       Impact factor: 4.818

5.  Resistance mutations and CTL epitopes in archived HIV-1 DNA of patients on antiviral treatment: toward a new concept of vaccine.

Authors:  Jennifer Papuchon; Patricia Pinson; Estibaliz Lazaro; Sandrine Reigadas; Gwendaline Guidicelli; Jean-Luc Taupin; Didier Neau; Hervé Fleury
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

6.  Kinetics of HIV-1 CTL epitopes recognized by HLA I alleles in HIV-infected individuals at times near primary infection: the Provir/Latitude45 study.

Authors:  Jennifer Papuchon; Patricia Pinson; Gwenda-Line Guidicelli; Pantxika Bellecave; Réjean Thomas; Roger LeBlanc; Sandrine Reigadas; Jean-Luc Taupin; Jean Guy Baril; Jean Pierre Routy; Mark Wainberg; Hervé Fleury
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

7.  CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.

Authors:  Roger Badia; Ester Ballana; Marc Castellví; Edurne García-Vidal; Maria Pujantell; Bonaventura Clotet; Julia G Prado; Jordi Puig; Miguel A Martínez; Eva Riveira-Muñoz; José A Esté
Journal:  Nat Commun       Date:  2018-07-16       Impact factor: 14.919

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.